Activated Rispharm™, the first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients, has been awarded the Exhibitor Innovation Award for Packaging Innovation at Pharmapack 2022.
The solution – which was showcased at the exhibition – impressed the Pharmapack Jury with its innovative packaging features, which prioritizes patient experience and safety, for improved health outcomes. Activated Rispharm provides patients with a hygienic application on every use of the multidose dropper, thanks to the proven and certified antimicrobial mineral protection of the cap and dropper tip where over 85 per cent of the contamination of drops is found according to clinical studies.
The launch is the result of a strategic commercial partnership between Berry Global, a leading provider of innovative and sustainable packaging and engineered products, and PYLOTE, a key player in the industrial mineral chemistry with expertise in helping to protect patients and users from the risk of microbial infections.
With a focus on sustainability, a key consideration in the product design was to enable a reduction in plastic waste. Activated Rispharm reduces the amount of plastic waste by 16 times for one month’s treatment compared to monodose solutions. In addition, Pylote’s patented mineral technology – microspheres – is embedded into the resin masterbatch, and is fully recyclable, thus supporting efforts towards sustainability.
Launched in 1997, the Pharmapack Awards celebrate the latest innovations from packaging companies within the drugs, medical devices, health products and veterinary drugs sectors. Judged by leading industry figures, the awards recognize innovations that have improved drug efficacy, user safety or reduced the environmental impact.
Activated Rispharm also made an immediate impact with visitors to Pharmapack. The solution was featured in the Innovation Gallery, which gives a great overview of recently launched products. An innovation Tour also stopped at the Berry booth for a dedicated presentation of Activated Rispharm to +20 professionals.
“We are extremely happy and honored to receive this Innovation Award from Pharmapack for our disruptive product Activated Rispharm. Our new antimicrobial multidose dropper will help fight against infection spread during ophthalmic delivery and treatment, supporting a better adherence and quality of life for patients,” says Mandy McCain, EVP Berry Global Healthcare.
“Infections are a major burden in ophthalmic that needs to be addressed with a sustainable multidose dropper. Activated Rispharm is the fantastic result of the very close collaboration between Berry Global and Pylote, as we aim to provide solutions that always protect and advance health globally.”
Learn more about our pharmaceutical plastic bottles and recyclable packaging solutions.